Pharmaceutical Biotechnology

Covid-19 Drug Development

COVID-19 drugs are the development is the research process to develop preventative therapeutic prescription medicines that would alleviate the severity of corona virus disease 2019 (COVID-19). Many hundred pharmaceutical companies, biotechnology units, university research associations, and healthcare organizations are developing therapeutic students for COVID-19 disease in multiple stages of preclinical or clinical research, with 419 potential COVID-19 drugs in clinical trials. Drug development is a multistep process, typically requiring more than five years to assure safety and efficacy of the new compound. Several national regulatory agencies, such as the EMA and the FDA, approved procedures to expedite clinical testing. Drug development is the process of bringing a new infectious disease vaccine or therapeutic drug to the market once a lead compound has been identified through the process of drug discovery.